What we do Albert David Ltd manufactures pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable medical products for domestic and export markets. |
Founded in 1,938 |
Market share Recognized as a large IV fluid manufacturer in India with a strong presence in pharmaceutical formulations and bulk drugs. |
Problem solved Provides quality healthcare products addressing medical infusion needs, herbal remedies, and bulk drug supplies to hospitals, clinics, and consumers. |
Top clients or who we serve Serves healthcare providers, pharmaceutical distributors, hospitals, and end consumers primarily in India with export outreach. |
Key management - |
Our journey and innovations Incorporated in 1938, established collaborations with Morishita Pharmaceuticals (Japan) and Pharma Plan (Germany), expanded product range with innovative drug launches over decades. |
Where we operate Primarily India, with exports to select international markets. |
Top products or what we offer Key offerings include IV fluids, amino acid infusions, capsules, antibiotics, vision care products, and disposable syringes and needles. |
Top brands - |
Raw materials needed Pharmaceutical chemicals, glass and polyethylene for containers, raw herbal ingredients, and materials for syringe manufacturing. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue is mostly recurring through sustained pharmaceutical sales and hospital supply contracts. |
Our industry position Well-established player in pharmaceutical infusion solutions and formulated drugs with competitive manufacturing capacity. |
Financial highlights FY 2025 revenue stood at Rs. 345.77 Cr with profit after tax of Rs. 17.2 Cr, reflecting investments in marketing and field force. |
Geographical revenue split - |
Order book - |
Whats driving growth Product portfolio expansion, strategic collaborations, and strengthened sales force driving future growth potential. |
Our future plans Focus on product innovation, capacity expansions, and improving market penetration across therapeutic segments. |
Our green promise Committed to sustainable manufacturing and ethical business practices as part of corporate governance. |
Our people and values Emphasizes healthy industrial relations and employee welfare across all manufacturing and sales units. |
Key challenges ahead Managing competitive market pressures and regulatory compliance to sustain profitability and growth. |
Interesting facts One of India’s early IV fluid manufacturers with technical partnerships from Japan and Germany enhancing product quality. |
Risks and strategy Mitigates financial and operational risks through strict internal controls, audits, and ongoing compliance systems. |
